Skip to main content

Table 2 Slope of risperidone utilisation between the four European countries after generic risperidone became available (month 0)

From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Country Slopea
Belgium −0.165
Ireland −0.143
Scotland −0.075
Sweden −0.194
  1. aA slope of −0.165 = a drop of 0.165%/month in the utilisation of risperidone as a percenage of all selected atypical antipsychotics following the introduction of generic risperidone.